Provided by Tiger Trade Technology Pte. Ltd.

IDEXX Laboratories

556.69
+1.700.31%
Pre-market: 556.690.00000.00%08:40 EDT
Volume:698.42K
Turnover:389.02M
Market Cap:43.91B
PE:39.12
High:561.24
Open:547.68
Low:543.60
Close:554.99
52wk High:769.98
52wk Low:518.55
Shares:78.88M
Float Shares:78.57M
Volume Ratio:1.93
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.23
EPS(LYR):13.08
ROE:74.21%
ROA:27.08%
PB:27.23
PE(LYR):42.56

Loading ...

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Alcon (ALC)

TIPRANKS
·
May 06

Idexx Laboratories (IDXX) Receives a Buy from Jefferies

TIPRANKS
·
May 06

Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785

MT Newswires Live
·
May 06

IDEXX Laboratories Inc : Jefferies Raises Target Price to $792 From $785

THOMSON REUTERS
·
May 06

IDEXX Laboratories Lifts Guidance on Robust Q1

TIPRANKS
·
May 06

Idexx Laboratories price target lowered to $660 from $790 at BofA

TIPRANKS
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel

Reuters
·
May 06

Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency

Benzinga Earnings
·
May 05

Sector Update: Health Care Stocks Higher Pre-Bell Tuesday

MT Newswires Live
·
May 05

IDEXX raises annual forecasts on strong pet diagnostics demand

Reuters
·
May 05

Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 Comparable EPS $3.30, vs. FactSet Est of $3.39

MT Newswires Live
·
May 05

IDEXX Laboratories Q1 Adj. EPS $3.30 Misses $3.40 Estimate, Sales $1.141B Beat $1.109B Estimate

Benzinga Earnings
·
May 05

BRIEF-IDEXX Q1 EPS USD 3.47

Reuters
·
May 05

IDEXX Q1 Gross Margin 63.4%

THOMSON REUTERS
·
May 05

IDEXX Outlook FY Revenue Growth 8.6-10.6%

THOMSON REUTERS
·
May 05

Top News Today/Canada: Government Pledges Additional C$1.5 Billion for Manufacturers

Dow Jones
·
May 05

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 02

IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 30

IDEXX Labs Is Maintained at Neutral by UBS

Dow Jones
·
Apr 28

UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating

MT Newswires Live
·
Apr 28